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Abstract
Background: Dried blood spots are a common medium for collecting patient blood prior to testing for malaria by
molecular methods. A new shaped filter device for the quick and simple collection of a designated volume of
patient blood has been designed and tested against conventional blood spots for accuracy and precision.
Methods: Shaped filter devices were laser cut from Whatman GB003 paper to absorb a 20 μl blood volume. These
devices were used to sample Plasmodium falciparum infected blood and the volume absorbed was measured
volumetrically. Conventional blood spots were made by pipetting 20 μl of the same blood onto Whatman 3MM
paper. DNA was extracted from both types of dried blood spot using Qiagen DNA blood mini or Chelex extraction
for real-time PCR analysis, and PURE extraction for malaria LAMP testing.
Results: The shaped filter devices collected a mean volume of 21.1 μl of blood, with a coefficient of variance of
8.1%. When used for DNA extraction by Chelex and Qiagen methodologies the mean number of international
standard units of P. falciparum DNA recovered per μl of the eluate was 53.1 (95% CI: 49.4 to 56.7) and 32.7 (95%
CI: 28.8 to 36.6), respectively for the shaped filter device, and 54.6 (95% CI: 52.1 to 57.1) and 12.0 (95% CI: 9.9 to 14.1),
respectively for the 3MM blood spots. Qiagen extraction of 200 μl of whole infected blood yielded 853.6 international
standard units of P. falciparum DNA per μlo fe l u a t e .
Conclusions: A shaped filter device provides a simple way to quickly sample and store a defined volume of blood
without the need for any additional measuring devices. Resultant dried blood spots may be employed for DNA
extraction using a variety of technologies for nucleic acid amplification without the need for repeated cleaning of
scissors or punches to prevent cross contamination of samples and results are comparable to traditional DBS.
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Background
The wide scale usage of dried blood spots (DBS) was
first introduced by Robert Guthrie in 1963 to facilitate
neonatal screening for phenylketonuria [1]. These con-
sisted of human blood applied directly onto an absorbent
cotton fibre filter paper and air dried for several hours in
order to immobilize the blood on the matrix and preserve
it. The DBS were simple to produce and could easily be
stored in sealed plastic bags and transported to the la-
boratory for subsequent processing, and even today are
considered as non-infectious material by International
Air Transport Association (IATA) regulations. Since
the first introduction of the Guthrie test, the range of
metabolic disorders, pharmacological studies, infectious
diseases and basic biological investigations to which DBS
have been applied has steadily increased [2-7] as have the
methodologies used to process them. By contrast, the pro-
cedures used to generate many such DBS have remained
practically identical to those first implemented by Guthrie.
For malaria, the usage of DBS for surveillance pro-
grammes remains particularly attractive. They provide the
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DOI 10.1186/s12936-015-0558-xability to collect, transport and store a large number of
blood samples for subsequent analysis using serological
[8] and nucleic acid based assays [9,10]. Traditionally a
number of different matrices have been available for cre-
ation of malaria DBS, such as the cotton cellulose 3MM,
903, GB002, GB003, GB004 papers (Whatman, GB) and
226 sample collection devices (Perkin Elmer, USA), the
glass fibre Wallac filter mat A (Perkin Elmer, USA) and
GF/C (Whatman, GB) papers and the non cellulose Bon-
dElut Dried Matrix Spotting paper (Agilent Technologies,
USA). Although, newer matrices such as FTA cards
(Whatman, GB), HemaForm (available as a stand alone
paper or within the HemaSpot device, Spot On Sciences,
USA) and Mitra (Phenomenex, USA) have been developed
to facilitate sample stabilization or recovery of biologically
active molecules, a great many of the dried blood spots
used in malaria programmes continue to employ cotton
cellulose papers.
Blood may be applied to such filter papers by pressing
the paper against a blood droplet at the site of a skin
prick, in which case the volume of the blood may be
crudely controlled by the diameter of DBS. Alternatively,
the use of a defined diameter punch can also approxi-
mate the sampling of a set volume of blood from a given
DBS, but several factors may impact on the precision of
these techniques [11]. A set volume of blood can be
measured volumetrically before application to the filter
paper to ensure consistency of sample size, using small
volume pipettes. In addition a variety of simple and
cheap devices have been designed specifically for blood
sampling to facilitate the use of rapid diagnostic tests
(RDTs). These include marked straws, open cups and
loops, however, a degree of inaccuracy has been reported
when using such devices [12], and such devices may not
measure the optimal volume for a given assay.
A number of nucleic acid extraction techniques have
been developed for DBS, including methanol, Chelex, TE
and enzymatic extraction [10,13], in addition to com-
mercial products such as the Instagene (Biorad, UK,)
ChargeSwitch Forensic DNA Purification (Invitrogen,
USA) and DNA blood mini (Qiagen, Germany) kits [6].
Prior to the deployment of such protocols, the DBS is
processed, either by cutting out some or all of the DBS
with scissors or punching out one or more disks from it.
In order to prevent cross contamination of samples the
punch or scissors are extensively cleaned in ethanol and
then used to make several cuts/punches in clean filter
paper. Several automated extraction techniques have
been published for the analysis of biological/pharmaco-
logical compounds, but all involve this manual step
[14-16]. The cutting of blood spots has been automated
by the use of a laser cutter [17], however, such a device
is not yet readily available for widespread use and could
conceivably be somewhat problematic to take into the
field. Disposable punches eliminate the need for repeated
cleaning of the punch, but consideration must be given to
the financial cost of these devices and the disposal of the
waste generated. Perforated DBS (pDBS) consist of a set
volume of blood applied to the centre of a circle of perfo-
rations on a filter paper, which is then dried. Upon ana-
lysis the entire disc is pushed out of the filter paper using
a disposable tip, eliminating the need for punches, but still
requiring the use of a set volume sampling device in
their generation [18]. The Mitra (RUO) microsampler
(Phenomenex, USA) has been recently developed to
sample and store a precise volume of blood, which can
then be processed without the need of a punch. How-
ever, as yet the device is limited to a 10 μlv o l u m ea n d
no data exists for its compatibility with DNA extraction.
Given the above limitations, a shaped filter device for
blood sampling and transport has been developed that is
cheap to manufacture and capable of quickly and easily
sampling 20 μl of blood from a finger prick with good
accuracy and precision. The device incorporates a stick
of filter paper for handling the device, which is kept free
of patient blood. This serves to minimize the potential
for cross contamination during the manipulation samples
(thereby eliminating the need for repeatedly cleaning the
cutting device) whilst protecting the user from exposure
to blood products. The device is compatible with Chelex,
Qiagen and PURE DNA extraction methodologies.
Methods
A commercial prototyping company was approached to
laser cut a defined volume shape (Figure 1a) from
Whatman GB003 paper, chosen for ease of cutting and
manipulation, combined with its high wicking capacity.
The shape comprised an inverted triangle of blotting
paper (to absorb the patient’s blood) joined to a thin
rectangle of blotting paper at its apex (for manipulation
of the sample). A single device comprised two of these,
assembled into a sleeve of polyester coated card (Figure 1b).
The sleeve is pre-folded so as to minimize the pressure
exerted by the card onto the sampling region of the device
(Figure 1c and f), with visual instructions printed on the
outside of the card to assist in its correct usage (Figure 1c).
The devices were cut and then hand assembled in clean
room conditions.
To assess the accuracy and precision of the prototype
shaped filter blood collection device, a 50 μl spot of
Plasmodium falciparum infected EDTA anticoagulated
blood was placed onto a weigh boat on a laboratory bal-
ance and the balance zeroed. The blood was absorbed
onto the collection device by touching the inverted tri-
angle against the blood spot (Figure 1d). The volume of
blood absorbed onto the device was controlled visually
by the operator, who was blinded to the reading on the
balance. When the blood reached the apex of the triangle
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to prevent any more blood being absorbed. The volume of
blood absorbed onto the collection device was determined
by the weight of blood removed from the blood spot
(1 mg=1 μl). This volume was recorded and the droplet
refreshed with 20 μl of blood. The balance was re-zeroed
and the process repeated. After ten weightings the weigh
boat was discarded and a fresh weigh boat used with a
fresh 50 μl droplet. This process was repeated to generate
a total of 80 separate measurements. In addition to these
80 samples, 80 traditional DBS were created by measuring
20 μl of the infected blood onto Whatman 3MM paper
using a Gilson P20 pipette. The blood spots on the shaped
filter device and 3MM paper were left to dry for four
hours at room temperature (23 degrees C) in a class II
microbiological cabinet with the fan on (Figure 1e). Fol-
lowing drying, they were stored in an air-tight box with
silica gel desiccant at −20 degrees C prior to use. The
blood used to create these DBS contained cultured 3D7 P.
falciparum ring stage parasites. Parasites were synchro-
nized in culture using sorbitol before being diluted down
in uninfected O-negative blood to the required density, as
determined by slide microscopy. Parasite density was
checked by extraction of DNA from two 200 μl aliquots of
the resultant blood and real-time PCR analysis of 2 μlo f
the DNA eluate as detailed below. The eluates were found
to contain 853.6 international standard units of parasites
DNA per μl using a real-time PCR targeting chromosomal
loci [19].
52 DBS on shaped filter devices were used for DNA
extraction; 28 were processed using a Chelex DNA
extraction protocol [10], and 24 were extracted with a
DNA blood mini kit (Qiagen, Germany) as per the
manufacturer’s protocols for DBS. The same number
of traditional DBS on 3MM paper was also extracted at
the same time using these same methodologies. Purified
DNA was used to quantify malaria DNA content using a
real-time PCR assay targeting the chromosomal 18S locus
[19] and a second in-house assay targeting the mitochon-
drial DNA [20] that was converted into a real time format
by the use of 1x QuantiTect SYBR green master mix [see
Additional file 1]. Assays were run on a Rotorgene-Q
(Qiagen, Germany). DNA was quantified against Qiagen
DNA mini-prep extracted samples of the 1
st WHO Inter-
national Standard for P. falciparum [21] diluted into unin-
fected human blood. The number of IUs per μlo fe x t r a c t
from these standards was calculated assuming a 100%
recovery of DNA into the eluate. Samples were run in
duplicate and the reference standard curve and parasite
concentration for DNA extracted from DBS calculated
automatically by the Rotor-Gene Q Series Software, ver-
sion 2.0.2 (Build 4) (Qiagen, Germany). The mean parasite
DNA concentration (in international IUs), standard devi-
ation and coefficient of variance were calculated for each
set of replicate blood spots processed with either Chelex
or Qiagen extraction methods.
DNA from 24 shaped filter DBS, 24 traditional 3MM
DBS and 24 20 μl blood samples was also extracted
using the PURE DNA clean up technology prior to their
analysis using the commercially available malaria LAMP
kit (Loopamp™ MALARIA Pan/Pf detection kit - LMC
562, Eiken Chemical Co., Ltd. Tokyo, Japan) as per
Figure 1 Shaped filter device for sampling and archiving 20μl of blood. a, the shaped filter insert laser cut from GB003. b, the insert
mounted inside a polyester coated, folded card sleeve. c, diagrammatic instructions for using the device printed on the sleeve. d, the device
being filled by placing it against a blood spot until the inverted triangle shape is filled. e unfolded, filled devices left to air dry.f, folded, filled
devices ready for storage. g, a single sample removed and cut for DNA extraction.
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was performed in an LA320CE real-time turbidimeter.
The mean time to positive turbidity (Tt) for each sam-
ple was converted into DNA concentration (expressed
as IUs per μl) using a standard curve of Tts generated
from PURE extracted DNA isolated from dilutions of
the international P. falciparum standard in uninfected
human blood. These dilutions were created to contain
10,000, 2,000, 400, 80 or 16 IU per μlb l o o da n dt h e
resulting PURE extracts were run in triplicate using
the Pf LAMP malaria test with a logarithmic standard
curve fitted to the output using Excel. The 200 μlo f
eluate was assumed to contain 100% of the DNA in the
original 20 μl of blood for compilation of the standard
curve. Converted Tts were used to calculate the mean
concentration of DNA per μl of extract for each type of
sample based, together with its standard deviation and
coefficient of variation. The amount of DNA extracted
from each type of blood spot and whole blood were
compared using unpaired t-tests assuming equal
variance.
Results and discussion
80 separate DBS generated using the shaped filter device
absorbed a mean blood volume of 21.1 μl when analysed
volumetrically, with a standard deviation of 1.7 μl. This
equates to a coefficient of variance of 8.1%. Based upon
these data 90%, 95% and 99% of fills are expected to lie
within +/−2.8 μl, +/−3.4 μl and +/−4.4 μl of the mean,
respectively.
When used for Chelex DNA extraction, DBS created
using the shaped filter device yielded a mean concentra-
tion of 53.1 (95% CI: 49.4 to 56.7) ISUs of parasite
chromosomal DNA per μl of eluate with a CV of 17.7%
(Table 1). In 28 replicate extractions the minimum and
maximum parasite concentrations per μl of eluate were
33.5 and 72.5 ISUs of parasite chromosomal DNA. The
traditional blood spots on 3MM paper gave an almost
identical yield of parasite chromosomal DNA, with a
mean concentration of 54.6 (95% CI: 52.1 to 57.1) ISUs
per μl of eluate. The CV of these eluates was 12.0% and
in the 28 replicate extractions the minimum and max-
imum concentrations of parasite chromosomal DNA
were 40.8 and 65.2 ISUs per μl of eluate. A t-test for un-
paired samples with equal variances showed no signifi-
cant difference in the level of chromosomal DNA
extracted from the two types of DBS (P= 0.461).
By comparison, when Qiagen blood DNA mini col-
umns were used to extract DNA, significantly more
chromosomal DNA was eluted from the shaped filter
compared to the traditional 3MM papers. The respective
mean DNA concentrations were 32.7 (95% CI: 28.8 to
36.6) and 12.0 (95% CI: 9.9 to 14.1) ISUs of parasite
chromosomal DNA per μl of eluate. The CV of the
eluates extracted from the shaped filter device and trad-
itional 3MM paper were 30.5% and 45.2% respectively
and the minimum and maximum yields of parasite
chromosomal DNA were 11.5 and 49.6, and 3.2 and 27.5
ISUs respectively. A t-test for unpaired samples with un-
equal variances showed the shaped filter paper yielded
significantly more malarial chromosome DNA than
blood spots on 3MM paper (P<0.0001).
DNA eluted from the two types of DBS was also com-
pared using a real-time assay targeted to mitochondrial
DNA (Table 1). In this assay, shaped filter papers again
produced significantly more DNA than the traditional
DBS when Qiagen technology was used in the extrac-
tions (P<0.0001). For Chelex extractions, however, trad-
itional DBS gave a significantly higher yield of parasite
mitochondrial DNA compared to shaped filter papers (P
<0.0001). It is worth noting, however, that mean DNA
yield from the shaped filter paper was only 28% lower
than that from the traditional DBS. Further optimization
of the extraction protocol for shaped filter papers may
be possible for mitochondrial targets.
Of significant interest for malaria screening pro-
grammes is the relative amounts of DNA recovered from
DBS using the Chelex procedure compared to whole
blood subject to Qiagen extraction. The concentration
of chromosomal DNA released by Chelex extraction of a
20 μl blood spot was less than 7% of that produced from
the 200 μl whole blood sample (853.6 ISUs of P. falcip-
arum DNA per μl of eluate). This is not surprising in
light of disparity of blood volumes processed by each
methodology; given both methods produce approxi-
mately the same volume of DNA eluate, the maximum
theoretical DNA concentration that may be liberated
from the Chelex processed DBS is tenfold less than
could be achieved using whole blood. Similar reductions
in DNA recovery between blood and filter papers have
been reported for human DNA [22], whilst DBS have
been shown to be qualitatively less good than whole
blood for malaria diagnosis [23]. This reduction in DNA
concentration may impose a significant limitation to the
level of sensitivity that can be achieved using DBS in epi-
demiological screening or “Find and Treat” programmes
unless more sensitive targets can be utilized for amplifi-
cation [24]. Where DBS and PCR have to be used, then
Chelex extraction would seem to outperform Qiagen
based DBS processing for detection of malarial DNA, a
phenomenon observed by other groups [9].
In the LAMP analysis, the mean concentration of P.
falciparum DNA (in IUs per μl of PURE extract) was
102.5 (95% CI: 89.5 to 115.5) for whole blood, 36.2 (95%
CI: 33.7 to 38.6) for 3MM DBS and 20.7 (95% CI: 17.1
to 24.2) for the shaped filter papers (Table 2). PURE elu-
ates derived from both sets of filter papers contained a
significantly lower number of IUs than PURE eluates
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ates). In real terms 3MM and GB003 based DBS yielded
36% and 20% of the level derived from whole blood.
The malaria LAMP kit has been shown to have an
LOD of 0.5 parasites per μl of whole blood when using
whole infected blood in the PURE extraction process
[23,24] a figure comparable to that achieved with nested
PCR and Qiagen purified DNA isolated from whole
blood [25,26]. The best level of DNA extraction achieved
with PURE extraction and DBS was 33% of the level
achieved using whole blood, which should equate to an
LOD of 1.5 parasites per μl of patient’s blood. By com-
parison, with only a 7% efficiency of DNA recovery from
DBS using Chelex extraction (compared to Qiagen pro-
cessing of whole blood), the theoretical LOD achievable
with DBS and nested PCR would be just over 7 parasites
per μl of patient blood. It would seem, therefore, that
where it is necessary to collect samples as DBS for mal-
aria surveillance or elimination, LAMP would appear
to be superior to PCR in the detection of low level infec-
tions (although this remains to be empirically tested). In
addition the PURE system can utilize wet as well as dried
blood spots. The PURE system has been developed to
allow the rapid (<20 minute) clean up of DNA for LAMP
in resource poor settings, but LAMP may be used with
other DNA sources including Chelex and Qiagen ex-
tracted DNA where time constraints allow. When 5 μlo f
DNA extracted from GB003 paper by the Chelex method
was used in the LAMP reaction the resultant Tts were
comparable to those obtained with PURE DNA from
whole blood [See Additional file 2]. It is feasible that an
LOD of 0.5 parasites per μl would be achievable with this
clean up system if time permitted the drying of filter pa-
pers and their overnight processing in saponin (these steps
being integral to Chelex clean up). 12.5 μlo fQ i a g e nD N A
showed an equivalent output to that obtained with PURE
extracted GB003 papers.
It should be noted that these data were generated with
a stringent protocol for the creation of traditional DBS,
namely the application of a defined volume of blood to
the filter paper measured using a calibrated low volume
pipette. The use of other devices such as straws or
Table 2 DNA concentration per μl of eluate determined in International Standard Units from PURE extracted DBS and
whole blood
Mean IU per μl eluate 95% CI Coefficient of variation Min IU per μl eluate Max IU per μl eluate t-test result
GB003 20.7 (17.1 to 24.2) 17.50% 7.7 35.5 <0.001
3MM 36.2 (33.7 to 38.6) 12.10% 26.3 46.3 <0.001
Raw blood 102.5 (89.5 to 115.5) 57.4 152.8
The Time to positive turbidity (Tt) achieved for each extract was converted into International Units (IUs) of DNA per μl of eluate by comparison to a standard
curve generated from PURE extracted blood containing different concentrations of the international standard for P. falciparum. The P values were generated by
comparing the level of DNA extracted from 3MM DBS and shaped filter devices (P < 0.001) or 3MM DBS and whole blood (P < 0.001) using two separate unpaired
t-tests. Assumptions of equal variance were tested by ensuring there was less than a twofold difference between the standard deviations of the two groups
compared before the tests were performed.
Table 1 DNA concentration per μl of eluate determined in International Standard Units from Chelex and Qiagen
extracted blood spots and whole blood
Mean ISU per
μl eluate
95% CI Coefficient of
variation
Minimum ISU
per μl eluate
Maximum ISU
per μl eluate
t-test
result
Chromosomal target (18 s)
Chelex GB003 53.1 (49.4 to 56.7) 17.7% 33.5 72.5
Chelex 3MM 54.6 (52.1 to 57.1) 12.0% 40.8 65.2 0.461
Qiagen GB003 32.7 (28.8 to 36.6) 30.5% 11.5 49.6
Qiagen 3MM 12.0 (9.9 to 14.1) 45.2% 3.2 27.5 <0.001
200 μ Raw blood 853.6 (790.3 to 917.0)
Mitchondrial target
Chelex GB003 62.7 (56.5 to 68.9) 24.9% 41.5 105.5
Chelex 3MM 84.9 (80.2 to 89.6) 14.0% 58.3 103.2 <0.001
Qiagen GB003 63.3 (59.8 to 66.9) 13.3% 44.2 75.6
Qiagen 3MM 42.7 (38.6 to 46.8) 22.5% 23.7 60.5 <0.001
200 μl Raw blood 1718.8 (1640.8 to 1796.8)
Two separate real-time PCRs were used to assay chromosomal (18 s) and mitochondrial loci. The P values were generated by comparing the level of DNA eluted
from 3MM and GB003 with Chelex or Qiagen DNA mini extractions using an unpaired t-test. Assumptions of equal variance were tested by ensuring there was less
than a twofold difference between the standard deviations of the two groups compared.
Polley et al. Malaria Journal  (2015) 14:45  Page 5 of 7attempting to control the volume by regulating the
diameter of the blood spot will in all likelihood signifi-
cantly increase the variance of the blood volume sam-
pled using traditional DBS. The use of a defined
diameter punch will only partially mitigate this since
blood is not evenly distributed across the filter paper in
DBS [27,28], and protocols which sample a defined frac-
tion of the blood spot (such as half or quarter of the
DBS) can in no way control for variability in blood spot
size and, therefore, the volume of blood assayed.
One significant difference between the shaped filter
paper and the traditional 3MM filter paper is the time
taken to process the sample for DNA extraction. The
elimination of ethanol flaming, cleaning scissors and
manually cutting blood spots reduces the processing
time of each DBS from 45 to 15 seconds, whilst cross
contamination is minimized by cutting a region of the
device not contaminated with patient blood. This paper
stick makes the sample much easier to handle, can be
torn away from a sleeved device (Figure 1g) and protects
the user from contamination with any blood products.
The prototype device had diagrammatic instructions
printed on the outside of the sleeve to aid its correct
use (Figure 1c). The rear of the device had a section for
filling in patient details together with Quick Response
Code stickers (Figure 1f) to allow electronic information
on a given patient to be linked to the relevant sample de-
vice. Such information could conceivably be entered using
a smart phone app during sample collection, and include
information such as a photograph to ensure that any treat-
ments triggered by a positive result are targeted to the
correct patient.
With a limited run of 5,000, it is estimated that the
combined cost for materials and manufacture of each
sampling device would be under 0.05 GBP (comprising
the device alone with no sleeve). Sleeved versions of the
sampling device would cost 0.30 GBP (hand assembled
with a polyester coated, pre-folded card sleeve). These
prices could well be reduced by manufacturing in bulk.
Alternatively, the ability to manufacture the insert alone
may represent a cost effective way for users to produce
their own sleeved devices on site. The flexibility of laser
cutting means that the device could be easily and
cheaply adapted to allow different blood volumes or add-
itional replicate samples to be collected according to a
user’s particular requirements.
Conclusions
Under these set of controlled conditions, it can be seen
that the shaped filter paper provides a quick and simple
way to sample and store blood in the form of dried
blood spots. The device performed well with Chelex,
Qiagen and PURE DNA extraction protocols compared
to traditional DBS and provides a level of precision and
accuracy comparable to a set volume of blood applied to
3MM paper using small volume pipettes. The next steps
will be to test the device with blood from finger pricks
in a malaria endemic location to evaluate its utility for
field based serological and nucleic acid based sampling.
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international standard for P. falciparum. The data present the time to
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present in each μl of the LAMP reaction.
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